In this retrospective cohort study of 1,901 pregnant women between 11 weeks and 13 weeks six days of gestation who had a nuchal translucency (NT) screening for fetal aneuploidies and demonstrated NT measurements > 95th percentile, 47% of fetuses (894/1,901) had an NT between the 95th and 99th percentile and 53% (1,007/1,901) had an NT ≥ the 99th percentile. In addition, of the 43% of fetuses (814/1,901) with at least one abnormality (structural or genetic), 34% (279/814) would have been missed in the first trimester if only cell-free deoxyribonucleic acid was used for prenatal genetic screening.
In this retrospective cohort study of women in Sweden, receipt of human papillomavirus vaccination prior to age 17 years was associated with an 88% decrease in cervical cancer, and vaccination at ages 17 to 30 years was associated with a 53% decrease in cervical cancer.
More than half of the 8 million depression-related provider visits in the United States occur in a primary care setting. The primary care provider is the most likely practitioner responsible for the detection and management of the disorder.
Women who seek most forms of contraception do not need a routine pelvic examination before they are prescribed a contraceptive. Still, these exams are routine for many OB/GYN offices and reproductive health clinics, and this creates a barrier for some women — particularly those who have experienced sexual assault and intimate partner violence, according to new research.
OB/GYNs and family planning clinicians should screen all patients for substance use disorders, as recommended by researchers and professional guidelines. Recent guidelines from the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice recommend anyone who enters a physician’s office for reproductive health services receive a screening for a substance use disorder.